🧬 The global antibiotic pipeline is dangerously thin, with only 90 antibiotics in development worldwide, and just a few targeting critical pathogens.
In this video, Benjamin Blasco explains how we're acting now to uncover new innovative antibiotics and improve existing ones.
#WAAW2025 #AMR #Antibiotics #ThisIsBig
❗️❗️ ¿Sabías que ya puedes acceder al catálogo de #Microbiología de @SEIMC_?
Este material, compuesto por distintas pruebas, muestras y microorganismos, sirve de apoyo a la #especialidad
Descubre todos los detalles 👇
https://t.co/mjBtaDpUgY
Can P. aeruginosa adopt an intracellular lifestyle? In #JBacteriology, researchers review studies that observe intracellular P. aeruginosa in vitro, as well as contextualize these findings with the few studies that report similar observations in vivo. https://t.co/3aicMQ0v0x
The final version of our manuscript is out in @NatureComms!🤩 Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance @besaraornottobe@LolleSigne@Rigshospitalet@DTUBiosustain 🧵👇https://t.co/xPKFmyVlhK
Second day of the PhD Training Course 2024: Extracellular vesicles for gene and cell therapies. - https://t.co/SzxH7Y5ouy -
The morning started with great science on Cell, Gene and EV therapy combinations for different aplications. Excellent talks from Karim Benabdellah, Lydi...
New paper from the lab published in @NatureMicrobiol. On cooperation, cheating, and beautiful patterns. @DukeUBME@DukeBiodesign, led by Nan Luo, @jialu_bio and @Emrah__Simsek, and in collaboration with @StuWest8. Tweetorial to follow. https://t.co/YDb8NEMsPH
La unidad de Microbiología Molecular del CIBIR ha presentado los resultados del proyecto de investigación en el que han logrado identificar dianas genéticas para el desarrollo de nuevos tratamientos que faciliten el control y erradicación de las infecciones por bacterias. #MICB
🦠 El CIBIR identifica dianas terapéuticas para el desarrollo de tratamientos innovadores capaces de combatir la resistencia a los antibióticos.
🖇️ https://t.co/dr3QQrZWFg
ICYMI: Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections @gardp_amr @NatRevDrugDisc https://t.co/nQwFoHcK23
The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental research https://t.co/84sw9j5LFS
We want to ensure you’ll be there for the 3rd International ECA coming up virtually on 1–15 Dec 2023! The event is FREE TO ATTEND.
Submit your abstract by 15th October 2023 at https://t.co/A0yeztYLex
We want to announce our esteemed committee member: Prof. Dr. Jordi Vila
Solo 6 #bacterias 🦠 se encargan de 71% de fallecimientos por infecciones !! 1.7 Millones de muertes al año:
E. coli
S. aureus
K. pneumoniae
S. pneumoniae
A. baumannii
P. aeruginosa
👇 @SEMicrobiologia@ANIH_1@uneatlantico@COSCEorg
https://t.co/Zo3TTtALCN
Spanish nation-wide analysis of P.aeruginosa susceptibility profiles and resistance genomics over the last five years.
A @ciberinfec @GemaraSeimc initiative led by @idisbaib@arpbigidisba@microhuse@SonEspases Group
https://t.co/a9KEDSTJoh